Back to
AVIVA PLC
MDGL
Showing 0 of 7 quarters
Position history for
AVIVA PLC's holdings in MADRIGAL PHARMACEUTICALS INC
No. Aviva exited its MDGL (Madrigal Pharmaceuticals) position in Q2 2021. Its Q1 2021 13F listed 10,495 shares worth $1.2M. Aviva first reported MDGL in Q4 2019 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.